On January 16, 2026, Wellgistics Health, Inc. entered into a note purchase agreement to issue up to $8.125 million in secured convertible promissory notes, with a purchase price of $6.5 million after a 20% discount. This agreement allows investors to convert notes into shares at $0.4057 each, incurring no interest unless there’s a default.